LoadingLoadingLoadingNo insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
Buys/Adds (2)
Citadel
$16.2M
added
Citadel
$26.3M
added
Top-trader positions in IMO could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Jul 31, 2026
Financial period
Q2
Earnings per share
$4.17 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 31, 2026 | $4.52 / $4.17Company release | +8.41% beat | CAD 16.07B No estimate | Unavailable |
| Mar 31, 2026 | May 1, 2026 | $1.94 / $2.40Alpha Vantage | -19.17% miss | CAD 12.45B No estimate | Unavailable |
| Dec 31, 2025 | Jan 30, 2026 | $1.97 / $1.89Alpha Vantage | +4.23% beat | $11.28B No estimate | Unavailable |
| Sep 30, 2025 | Oct 31, 2025 | $2.17 / $1.96Alpha Vantage | +10.71% beat | CAD 16.20B No estimate | Unavailable |
| Jun 30, 2025 | Aug 1, 2025 | $1.86 / $1.61Alpha Vantage | +15.53% beat | CAD 11.21B No estimate | Unavailable |
| Mar 31, 2025 | May 2, 2025 | $2.52 / $2.16Alpha Vantage | +16.67% beat | CAD 12.47B No estimate | Unavailable |
| Dec 31, 2024 | Jan 31, 2025 | $2.37 / $2.18Alpha Vantage | +8.72% beat | CAD 12.70B No estimate | Unavailable |
| Sep 30, 2024 | Nov 1, 2024 | $2.33 / $2.01Alpha Vantage | +15.92% beat | CAD 13.21B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Jun 2022 | Sep 2022 | Sep 2023 | Dec 2025 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $17.29B | $15.07B | $13.87B | $11.28B |
| Cost of what it sold | $13.48B | $11.93B | $11.07B | $9.36B |
| Gross profit | $3.80B | $3.14B | $2.81B | $1.92B |
| What it spent | ||||
| Research and development | — | — | — | $134.0M |
| Sales and admin | $196.0M | $213.0M | $257.0M | $216.9M |
| Other operating costs | — | — | — | $946.1M |
| Total operating expenses | $197.0M | $214.0M | $258.0M | $1.30B |
| What was left | ||||
| Operating profit | $3.61B | $2.92B | $2.55B | $625.0M |
| Interest on debt | $11.0M | $16.0M | $19.0M | $10.0M |
| Profit before tax | $3.17B | $2.50B | $2.10B | $629.0M |
| Tax | $757.0M | $474.0M | $499.0M | $137.0M |
| Net profit | $2.41B | $2.03B | $1.60B | $492.0M |
| EBITDA | $3.61B | $2.92B | $2.55B | $1.29B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
